News & Resources
Patent Office Disbands Warning System; Defenses Still in Place
Posted on Mar 25, 2015 in Articles
Earlier this month, the U.S. Patent and Trademark Office canceled an internal program that had been designed to flag patent applications of questionable subject matter. The Sensitive Application Warning System (SAWS) had existed for many years as a way for the patent office to try to prevent the issuance of patents that were “controversial and noteworthy.” Although the program no longer exists, there are still mechanisms in place to prevent such patents from issuing.
Read MoreCaesar Rivise Obtains Federal Circuit Affirmance of a Denial of a Motion for Preliminary Injunction
Posted on Mar 13, 2015 in News
On March 12, 2015, the United States Court of Appeals for the Federal Circuit ruled in favor of Caesar Rivise clients Camber Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc. in a case filed by Roxane Laboratories, Inc. alleging infringement of its patent covering calcium acetate capsules and their use in the treatment of hyperphosphatemia in patients with chronic kidney disease.
Read MoreCaesar Rivise Client Katy C. Worrilow, Ph.D., Founder and CEO of LifeAire Systems, Named Entrepreneur of the Year
Posted on Mar 12, 2015 in News
Katy C. Worrilow, Ph.D., Founder and CEO of LifeAire Systems, has been named Entrepreneur of the Year by the Lehigh Valley Economic Development Corporation (LVEDC) and will be presented with the award during LVEDC’s 2015 Annual Investors Meeting and Awards ceremony on March 18th.
Read MoreStandards-Setting Body in the IP News Over Policy Change
Posted on Feb 25, 2015 in Articles
If someone does not have a technical background, then he or she may have never heard of the Institute of Electrical and Electronics Engineers, but IEEE plays a huge role in many of the most popular electronic devices that are used today. IEEE, of which I am a proud member, is the world’s largest association of technical professionals, with more than 400,000 members worldwide. IEEE has recently been in the news because of a significant policy change that will affect the patent rights of many patent holders. In fact, the policy change has initiated significant controversy, because while some technology users will benefit from this change, some patent owners have expressed not only dismay and concern, but outright defiance.
Read MoreHague Agreement Adoption by U.S. Will Reduce Barriers to Global Protection of Designs
Posted on Feb 23, 2015 in Blog
U.S. applicants interested in protecting their designs outside the U.S. will soon have the option of filing a single international design patent application under the Hague Agreement. The Hague Agreement goes into effect in the U.S. on May 13, 2015.
Read More特許が「質」と定義される意味とは?
Posted on Jan 28, 2015 in Articles
クライアントに業務を取り扱う弁護士に何を期待するか尋ねてみてください。その答えは、業務に「質」が伴うことでしょう。誰でも、法律サービスを購入すると、代わりに質を手に入れると考えます。しかし、特許の分野において、特許が質を持つ意味とは何ですか?
Read MoreWhat Does It Mean for a Patent to Be Defined as ‘Quality’?
Posted on Jan 28, 2015 in Articles
Ask any client what he or she expects from the lawyers who are handling his or her work, and invariably the answer you receive is that the work must possess “quality.” Everyone wants to know that when they purchase legal services, they will get quality in return. But in the patent realm, what does it mean for a patent to have quality?
Read MoreUse of Data Analysis Tools by Caesar Rivise Attorneys Featured in National Legal Periodical Article
Posted on Jan 27, 2015 in News
Caesar Rivise Managing Partner, David Tener, is featured in an article relating to the firm’s use of Patent Advisor, a data analysis tool for patent prosecution in the U.S. Patent and Trademark Office. Attorneys at the firm use Patent Advisor to analyze the performance statistics of examiners when formulating a prosecution strategy for firm clients.
Read MoreU.S. Buyers and Their Legal Advisors Beware: Indian Court’s Injunction Against Glenmark’s Continued Infringement of Symed Lab’s Process Patent Suggests That Pharmaceutical Method Claims Are Becoming More Readily Enforceable in India
Posted on Jan 23, 2015 in Blog
An ad interim injunction passed by the Honorable Delhi High Court (on January 19, 2015) against Glenmark restrained infringement of Symed’s Process Patent Nos. IN 213062 and IN 213063.
Read MoreSupreme Court in Teva v. Sandoz Holds That Claim Construction Facts Must Be Reviewed Under Clear Error Standard On Appeal
Posted on Jan 20, 2015 in Blog
On Tuesday, January 20, 2015, in Teva Pharmaceuticals USA Inc. et al. v. Sandoz Inc. et al., case number 13-854, the United States Supreme Court, in a 7-2 decision by Justice Breyer abolished the CAFC’s en banc practice that claim construction rulings of the district court be reviewed de novo. Instead, the Court ruled that these ruling must be entitled to deference of the district court’s factual findings as Teva had requested in a dispute regarding its highly profitable Copaxone product for multiple sclerosis.
Read More